Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients

BACKGROUND: The benefit of chemotherapy in colon cancer patients is well documented but depends largely on whether patients complete the planned treatment regimen. We evaluated predictors of early discontinuation (EDChemo) and dose reduction of chemotherapy, especially the role of adverse treatment...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Med Oncol
Asıl Yazarlar: Boakye, Daniel, Jansen, Lina, Halama, Niels, Chang-Claude, Jenny, Hoffmeister, Michael, Brenner, Hermann
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8072866/
https://ncbi.nlm.nih.gov/pubmed/33995589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211006348
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller